Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants (Q34441406)

2 August 2017

1 reference

title

Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants (English)

1 reference

2 August 2017

Amaral L

1

1 reference

2 August 2017

Kristiansen JE

series ordinal

2

1 reference

2 August 2017

publication date

1 November 2001

1 reference

International Journal of Antimicrobial Agents

2 August 2017

published in

1 reference

2 August 2017

volume

18

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

411-417

1 reference

Prion diseases of humans and animals: their causes and molecular basis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Prion protein and developments in its detection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

The potential management of resistant infections with non-antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Antibacterial effect of four phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Effects of chlorpromazine on the cell envelope proteins of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Synergic effect of chlorpromazine on the activity of some antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pyroli

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Virus inactivation of fresh plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inactivation of viruses in human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of SV40 DNA replication in vitro by chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of arenavirus multiplication in vitro by phenotiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of measles virus budding by phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Verapamil and chlorpromazine inhibit the budding of Sindbis and vesicular stomatitis viruses from infected chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Examination of potential inhibitors of hepatitis A virus uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of HIV infection of H9 cells by chlorpromazine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Activity of Oral Drugs against Leishmania Tropica in Human Macrophages in Vitro *

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Antileishmanial activity of chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

The effects of chlorpromazine on the outer cell wall of Salmonella typhimurium in ensuring resistance to the drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Sublethal concentrations of antibiotics, effects on bacteria and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Penicillin-binding site on the Escherichia coli cell envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Cancer research 2000: drug resistance, new targets and drugs in development.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Monitoring interactions at ATP-dependent drug efflux pumps

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Rapid detection of efflux pumps and their relation with drug resistance in yeast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Drugs and DNA: Uncoiling of the DNA double helix as evidence of intercalation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

ESR spectroscopy of flow-oriented cation radicals of phenothiazine derivatives and phenoxathiin intercalated in DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Regulation of erythrocyte ghost membrane mechanical stability by chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Regulation of endocytic traffic by rho family GTPases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Inhibition by trifluoperazine and digitonin of several forms of pinocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Membrane environment alters the conformational structure of the recombinant human prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Modifications of oligodendroglial cells in spongiform encephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

A protease-resistant protein is a structural component of the scrapie prion.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Cleavage of the amino terminus of the prion protein by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Methylene blue derivatives--suitable photoantimicrobials for blood product disinfection?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Drug-Induced Agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

Photoinduced free radicals from chlorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900432-0

7 January 2021

10.1016/S0924-8579(01)00432-0

Identifiers

DOI

1 reference

2 August 2017

1 reference